The therapeutic potential of andrographolide in cancer treatment

This publication has 153 references indexed in Scilit:

• Andrographolide reverts multidrug resistance in KBCh^R 8‐5 cells through AKT signaling pathway
  Cell Biochemistry and Function, 2024
• Andrographolide inhibits Burkitt’s lymphoma by binding JUN and CASP3 proteins
  Cancer Chemotherapy and Pharmacology, 2023
• Cytotoxic and Anti‐Inflammatory Activity of 3,19‐Isopropylidene‐/Arylidene‐Andrographolide Analogs
  Chemistry & Biodiversity, 2023
• Andrographolide suppresses breast cancer progression by modulating tumor‐associated macrophage polarization through the Wnt/β‐catenin pathway
  Phytotherapy Research, 2022
• Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches
  Phytotherapy Research, 2021
• The ever‐increasing importance of cancer as a leading cause of premature death worldwide
  Cancer, 2021
• Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
  Clinical Pharmacology & Therapeutics, 2018
• Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF‐1/SOX9 Axis
  Journal of Cellular Biochemistry, 2017
• SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells
  Cell Biology and Toxicology, 2014
• In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog
  Investigational New Drugs, 2014